Trials / Completed
CompletedNCT00168974
Neuropathic Pain and Fabry Disease
Somatosensoric and Autonomic Disturbances in Female Patients With Fabry Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (planned)
- Sponsor
- Danish Pain Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Fabry disease is a rare X-linked lysosomal storage disorder. The mutations result in a deficiency of the lysosomal enzyme α-galactosidase causing accumulation of glycosphingolipids in the vascular endothelial cells and many other tissues. An early sign of the disease is painful small fibre neuropathy presenting in two forms: 1. a constant burning sensation in the hand and feet and 2. Fabry crises consisting of attacks of excruciating pain. Given the X-linked inheritance, male patients are severely affected. Recently attention has been drawn to female patients whether they also show signs of nerve involvement. The purpose of this study is to evaluate the small fibre neuropathy in female Fabry patients. Correlation with X-chromosome inactivation will be attempted. Recombinant human α-galactosidase A is now available for patients. A part of this study is evaluation the long term efficacy of enzyme replacement therapy in female patients with Fabry disease and neuropathy. Male family members with Fabry disease will be examined.
Conditions
Timeline
- Start date
- 2004-01-01
- Completion
- 2007-11-01
- First posted
- 2005-09-15
- Last updated
- 2007-11-16
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00168974. Inclusion in this directory is not an endorsement.